The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid

Tomiko Sunaga,Kazushi Shimamoto,Shoko Nakamura,Noriko Takahashi,Mayumi Higashino,Tomomi Hozumi,Mitsuki Matsui,Akiko Nagatani,Fumio Kokubu,Mari Kogo,Tadanori Sasaki

The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid

2017

Tomiko Sunaga
Kazushi Shimamoto
Shoko Nakamura
Noriko Takahashi
Mayumi Higashino
Tomomi Hozumi
Mitsuki Matsui
Akiko Nagatani
Fumio Kokubu
Mari Kogo
Tadanori Sasaki

Zoledronic acid is an established agent used in the management of metastatic bone disease. The administration of zoledronic acid improves overall survival (OS) of lung cancer patients with bone metast

Keywords:

Bone disease
Immunology
Biology
Cancer research
Zoledronic acid
Lung cancer
Surgery
Toxicity
Internal medicine
overall survival
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations